CERE - Cerevel Therapeutics Hldg Insider Trades Send a Signal | Benzinga
BAIN CAPITAL INVESTORS LLC, 10% Owner at Cerevel Therapeutics Hldg (NASDAQ:CERE), reported a large insider buy on October 18, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that LLC purchased 5,480,052 shares of Cerevel Therapeutics Hldg. The total transaction amounted to $124,999,986.
Cerevel Therapeutics Hldg shares are trading up 4.58% at $23.75 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an ...